Almac to offer pre-clinical screening packages

The package is designed to identify candidates with drug product like characteristics and to highlight the potential pitfalls associated with the molecules.

Experimental efforts focus on establishing the physical/chemical, solubility, stability and polymorphic characteristics of every candidate.

Almac Physical Sciences head Linda McCausland said the package will allow a rapid decision on whether to progress candidates further through early stage development.

"With speed to market being the most critical factor in sustainable drug development, utilising this service can make a real difference in investment and timelines," McCausland added.

Almac’s solid state services group are equipped with analytical research and development technologies and specialise in solid form characterisation, screening and selection and crystallisation process development.